4.8 Article

TLQP-21 is a low potency partial C3aR activator on human primary macrophages

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

Eduardo A. Albornoz et al.

Summary: COVID-19 infection may lead to neurological symptoms similar to Parkinson's disease. The study found that SARS-CoV-2 and spike protein can directly activate the NLRP3 inflammasome in microglial cells, which may contribute to the development of neuroinflammation.

MOLECULAR PSYCHIATRY (2023)

Review Biochemistry & Molecular Biology

The molecular identity of the TLQP-21 peptide receptor

Bhavani S. Sahu et al.

Summary: The review critically evaluates the molecular identity of the TLQP-21 receptor and the proposed multi-receptor mechanism of action, confirming a critical role for C3aR1 in TLQP-21 biological activity, while data supporting a role of gC1qR and HSPA8 remain limited.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Immunology

Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists

Xaria X. Li et al.

Summary: The complement system is a crucial component of innate immunity, generating effector cleavage proteins C3a and C5a that interact with three seven-transmembrane receptors. Studies suggest that commonly used C5a agonists may lack selectivity among the anaphylatoxin receptors.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Anatomy & Morphology

TLQP-21 changes in response to a glucose load

Giulia Corda et al.

Summary: The study showed that TLQP-21 peptide may be released from islets under hyperglycemic conditions to enhance insulin secretion. C3a-R1 was localized in approximately 50% of TLQP-labeled islet cells, while gC1q-R was detected in around 25% of the cells.

TISSUE & CELL (2021)

Article Chemistry, Medicinal

Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo

Declan M. Gorman et al.

Summary: C5a is an important mediator of inflammation associated with immune disorders, binding and activating the receptors C5aR1 and C5aR2. Laboratory sources of C5a include isolation from serum, recombinant expression, and chemical synthesis which offers advantages like introducing modifications and reducing contamination. Synthetic C5a peptides have been validated for functionality compared to native or recombinant C5a in various cell types and assays, providing valuable alternatives for experimental use.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Article Biochemistry & Molecular Biology

TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β

Kwangmin Cho et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling

Elena Bresciani et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Emerging Insights into the Structure and Function of Complement C5a Receptors

Shubhi Pandey et al.

TRENDS IN BIOCHEMICAL SCIENCES (2020)

Article Endocrinology & Metabolism

Clearance kinetics of the VGF-derived neuropeptide TLQP-21

ZengKui Guo et al.

NEUROPEPTIDES (2018)

Article Pharmacology & Pharmacy

Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells

Laura Molteni et al.

FRONTIERS IN PHARMACOLOGY (2017)

Article Endocrinology & Metabolism

The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis

Cheryl Cero et al.

MOLECULAR METABOLISM (2017)

Article Cell Biology

Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling

Daniel E. Croker et al.

IMMUNOLOGY AND CELL BIOLOGY (2016)

Article Pharmacology & Pharmacy

Derivation of ligands for the complement C3a receptor from the C-terminus of C5a

Reena Halai et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Article Biochemistry & Molecular Biology

Identification of a Receptor for Neuropeptide VGF and Its Role in Neuropathic Pain

Ya-Chun Chen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

Identification of the C3a Receptor (C3AR1) as the Target of the VGF-derived Peptide TLQP-21 in Rodent Cells

Sebastien Hannedouche et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Review Pharmacology & Pharmacy

International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors

Andreas Klos et al.

PHARMACOLOGICAL REVIEWS (2013)

Article Immunology

Defining GM-CSF- and Macrophage-CSF Dependent Macrophage Responses by In Vitro Models

Derek C. Lacey et al.

JOURNAL OF IMMUNOLOGY (2012)

Article Biochemical Research Methods

A novel in vitro human microglia model: Characterization of human monocyte-derived microglia

Samar Etemad et al.

JOURNAL OF NEUROSCIENCE METHODS (2012)